“borderline significant”

Comparison of birefringence values between diabetic subjects with no clinically manifest DR versus mild to moderate DR stages revealed a borderline significant difference (0.0065 [–0.000004; 0.0130], P = 0.050; Fig. 2 ).

Borderline significant associations were noted for CLL incidence and mortality (p = 0.050).

OS showed a borderline significant association with IGKC expression in Kaplan Meier analysis in ER positive carcinomas (Log-rank test: P = 0.050; Fig. 3D ).

A borderline significant reduction in the composite of HF hospitalization or cardiovascular death was seen with SGLT2 inhibitor use [HR: 0.80 (0.63–1.00); P = 0.05; I 2 = 29%].

Likewise, the fully adjusted association of hsCRP with CVD events was borderline significant when expressed per SD change (HR 1.16 (95% CI: 1.00–1.35), P = 0.05).

Correlations of hypoglycemic events and overall glucose control We observed a negative correlation between eHbA1c and total daily and mild hypoglycemic events (r=−0.57 and r=−0.66, respectively, p<0.0001), while for serious hypoglycemic events there was a borderline significant correlation (r=−0.13, p=0.05) ( figure 3 ).

In the unadjusted comparison of outcomes between the IMN and ORIF pairs, there were no statistically significant differences, although the greater prevalence of revisions in the ORIF cohort was borderline significant ( p = 0.05) (Table 3 ).

The HRs for the continuous PRS were not significantly different between the BCFR and kConFab study cohorts (p=0.13) for study*PRS interaction, but were borderline significant for the upper vs. lower quintile (P=0.05), nor did the HR vary significantly as a function of age at baseline (p=0.88 and p=0.71 for the two cohorts, respectively).

After adjustment for sex, BSA remained a significant correlate of LVEDID, LVEDL and LVEDV (p<0.01 for all), and also remained a borderline significant correlate of LV mass (p<0.05), but was no longer a correlate of LV end-diastolic external diameter.

BUN was borderline significant (β = 3.5, p = 0.05).

Gender was found to be borderline significant in univariate analysis ( p = 0.05) but not significant in multivariate models, which is in line with our findings regarding gender 31 .

Secondary Outcomes: Total and Aerobic Activity Times In phase I (Table 2 ), the unblinded and blinded groups were not significantly different in modifying their total activity times, whereas there was a borderline significant smaller decrease in aerobic time in unblinded patients (differential 8 minutes; 95% CI, 0 to 16; P =0.05).

Kruskal-Wallis testing showed a borderline significant difference (p = 0.05) among the iris reflectances for the iris colors.

PBM vs Control: PBM showed a borderline significant improvement compared to Control (-0.52 mm, p=0.050) with a small to moderate effect size.

Four additional transcripts in genes angiotensin I converting enzyme ( ACE ), SLC22A1 and CYP3A7 (two transcripts) were borderline significant ( P <0.05).

After log transformation, the means for supportive PET/CT and non-contributory PET/CT were 7.4 ± 2.01 and 4.5 ± 2.07, respectively, with a borderline significant P = 0.05.

Specifically, BTS treatment at 300 mg/kg successfully reduced the increase in IL-1β ( p < 0.01) and showed a borderline significant reduction in TNF-α ( p = 0.05).

In the age-stratified analysis, individuals aged ≥65 years showed a borderline significant association between METS-IR and GC risk, with an adjusted HR of 1.12 (95% CI: 1.00–1.26; p = 0.05) in Q4 compared to Q1.

With an ICP threshold of ≥22 mmHg, logistic regression yielded an OR of 2.8 (1.4; 5.7, p = .00) for ONSDext and a borderline significant OR of 3.2 (1.0; 10.3, p = .05) for ONSDint.

The distribution of patients across plasma 25(OH)D groups (deficient, optimal) presented a borderline significant difference ( p = 0.05) between case and control groups with higher distribution of patients with autoimmune diseases in deficient vitamin D group.

The meta-analysis of the comparison of the means of three studies that compared NHD patients with a follow up period of 4–6 months with control patients that continued on CHD for 4–6 months showed a borderline significant increase in serum albumin in NHD patients (mean difference 1.3 g/l, 95% CI 0.02; 2.58, P = 0.05) ( Fig 2b ).

After treatment, the CRADI domain of the PFDI-20 questionnaire had a borderline significant difference between the two groups (P=0.05), but there were no statistically significant differences in terms of UDI (P=0.21) and POPDI (P=0.81) between the groups.

evansi was higher than in the other breeding systems (borderline significant, p = 0.05).

5 C – H ); however, PR4 up-regulation was only borderline significant ( P = 0.05).

Although RMT also showed a trend toward improved quality of life (SMD 1.00, 95% CI 0.00-1.99; P = .05), this result was borderline significant and derived from only three studies and should therefore be interpreted cautiously.